News Headlines Article

Federal Panel Split on Ban of Weight-Loss Drug
New York Times

A federal advisory panel was divided Wednesday over whether to recommend banning a weight-loss drug made by Abbott Laboratories, although a majority agreed that the drug’s heart risk cast a shadow on its future use.

Eight of the 16 members of the Food and Drug Administration’s panel of outside advisers urged withdrawing the drug, Meridia, saying the potential for heart attacks and stroke outweighed any benefits of minor weight loss.